Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217100 · ClinicalTrials.gov registry record · Phase 3
A Multivitamin Comparison Study in Kidney Transplant Recipients.
A Phase 3 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
NCT00217100: Completed Phase 3 study, sponsored by Mayo Clinic.
NCT00217100 is a Phase 3 study that has completed, run by Mayo Clinic. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00217100, a Phase 3 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
Study Summary
This study is being done to compare arteriosclerotic cardiovascular disease in kidney transplant recipient taking a standard multivitamin versus those taking a multivitamin augmented by a high dose combination of folic acid, vitamin B12, and vitamin B6.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Multivitamin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2004-10 |
| Est. Completion | 2010-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00217100
The ClinicalTrials.gov registry entry for NCT00217100 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00217100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00217100 about?
NCT00217100 is a clinical study titled "A Multivitamin Comparison Study in Kidney Transplant Recipients.". This study is being done to compare arteriosclerotic cardiovascular disease in kidney transplant recipient taking a standard multivitamin versus those taking a multivitamin augmented by a high dose combination of folic acid, vitamin B12, and vitamin B6.
What is the current status of trial NCT00217100?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2004-10. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00217100?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Multivitamin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00217100?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.